4Nodari S, Metra M, Cas AD, et al. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant dia betes mellitus[J]. Eur J Heart Fail, 2003, 5(6):803-809.
5Schleman KA, Lindenfeld JA, Lowes BD, et al. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis[J]. J Card Fail, 2001, 7(I): 4-12.
6Lenarda AD, Remme WJ, Charlesworth A, et al. Exchange of 13-lockers in heart failure patients.Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial)[J]. Eur J Heart Fail, 2005, 7(4):640-649.
7Pitt B, Pcole-Wilson PA,Segal R,et al. Effect of losartan compared with captopril mortality in patients with symptomatic heart failure: Randomized trial-the losartan heart failure survival study ELITE Ⅱ [J]. Lancet,2000,355(9215) :1582-1587.
8Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113:1807-1816.
